Jaume Pons - 05 Aug 2022 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role: President & CEO, Director
Signature: /s/ Peter Garcia, by power of attorney
Issuer symbol: ALXO
Transactions as of: 05 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Aug 2022, 17:55:13 UTC
Previous filing: 07 Feb 2022
Next filing: 03 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALXO	Common Stock	Award	$0	+74,000	+16%	$0.000000	542,978	05 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALXO	Employee Stock Option (right to buy)	Award	$0	+244,000		$0.000000	244,000	05 Aug 2022	Common Stock	244,000	$11.47	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022.
F2	Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022.